BioSpace News Archive

- Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced the presentation of new clinical data from three ongoing trials of Ad-RTS-hIL-12 plus veledimex (Controlled IL-12) for the treatment of recurrent glioblastoma (rGBM) and diffuse intrinsic pontine glioma (DIPG) at the 2020 Society for Neuro-Oncology (SNO) Annual Meeting.

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has announced William Dauer , MD, director of the Peter O’Donnell Jr. Brain Institute and professor of neurology and neuroscience at the University of Texas Southwestern Medical Center in Dallas , as the recipient of the sixth annual Bachmann-Strauss Prize for Excellence i

Neurocrine Biosciences, Inc. announced that Neurocrine Biosciences management will present at the following investor conferences:.

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it has appointed Dr. Monica Bertagnolli to its board of directors.

Invitation-Only Digital Gathering Encouraged Collaboration and Delivered Value to Customers

TrialAssure® – a leading, global software company advancing clinical trial disclosure and data transparency – has released its latest version of ANONYMIZE for Documents, including the functionality to anonymize and redact PDF documents concurrently.

New digital health trial will leverage state-of-the-art tech to detect and predict myasthenia gravis symptom patterns and flares

Contract research organization deepens its global bench of oncology experts to help sponsors achieve breakthroughs for cancer patients

Perimeter Medical Imaging AI, Inc. was recognized as one of the 10 Most Promising Companies at the 2020 Texas Life Science Forum

Grant is in Honor of Two-Year-Old Georgia Bowen Who was Born in Cardiac Arrest and Saved by Doctors at Boston Children’s Hospital